A61K 39/0012
Lipids
Official title: {Lipids; Lipoproteins}
A61K39/0012 (Lipids) appears on 41 US grants and 98 published applications in this corpus.
Search patents in A61K- Granted patents
- 41
- Published applications
- 98
- Assignees
- 66
- Inventors
- 206
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 2 |
| 2003 | 1 | 5 |
| 2004 | 0 | 9 |
| 2005 | 0 | 1 |
| 2006 | 1 | 1 |
| 2007 | 1 | 4 |
| 2008 | 0 | 2 |
| 2009 | 1 | 4 |
| 2010 | 0 | 2 |
| 2011 | 0 | 2 |
| 2012 | 0 | 2 |
| 2013 | 2 | 3 |
| 2014 | 1 | 6 |
| 2015 | 7 | 5 |
| 2016 | 1 | 3 |
| 2017 | 2 | 4 |
| 2018 | 1 | 4 |
| 2019 | 3 | 5 |
| 2020 | 3 | 7 |
| 2021 | 3 | 4 |
| 2022 | 2 | 4 |
| 2023 | 2 | 3 |
| 2024 | 1 | 4 |
| 2025 | 1 | 8 |
| 2026 | 3 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Edible plant exosome-like nanovectors for vaccination11 Aug 2026US 12,702,703 B2University of Louisville Research Foundation, Inc.
- Chimeric Tim receptors and uses thereof9 Jun 2026US 12,648,964 B2Cero Therapeutics Holdings, Inc.
- Varicella zoster virus (VZV) vaccine12 May 2026US 12,622,960 B2ModernaTX, Inc.
- Compositions and methods for modified dendrimer nanoparticle delivery23 Sep 2025US 12,419,940 B2Massachusetts Institute of Technology
- Varicella zoster virus (VZV) vaccine5 Mar 2024US 11,918,644 B2ModernaTX, Inc.
- Ultrapurified Phospholipoproteomic Composition for High-Purity Biomolecular Research and Precision Therapeutics14 May 2026US 2026/0130978 A1Aetherion Global LLC
- Polynucleotides and lentiviral vectors expressing non-structural antigens of a flavivirus selected from the group of denv, zikv and yfv, inducing protective cd8+ t-cell immunity in a host9 Apr 2026US 2026/0097108 A1
- Veterinary compositions of modified virus-like particles of cmv and ngf antigens12 Mar 2026US 2026/0069668 A1
- Modified virus-like particles of cmv26 Feb 2026US 2026/0055428 A1Saiba Animal Health AG
- Methods for inhibiting trained immunity with nanobiologic compositions3 Jul 2025US 2025/0213665 A1Icahn School of Medicine at Mount Sinai
Most cited
By later US patents
- Varicella zoster virus (VZV) vaccine66US 11,045,540 B2ModernaTX, Inc. · 2021
- Method for immunization of mammals against atherosclerosis and pharmaceutical compositions for obtaining said immunization40US 5,424,068 AP. Doina International Ltd. · 1995
- Antigen-based treatment for adiposity28US 5,096,706 ANational Research Development Corporation · 1992
- Vaccines against sterols4US 5,753,260 AEntreMed, Inc. · 1998
- Modulation of cholesteryl ester transfer protein (CETP) activity4US 6,410,022 B1Avant Immunotherapeutics, Inc. · 2002